SEC Comment Letter 0000000000-23-011929 to enVVeno Medical Corp (NVNO)
enVVeno Medical Corp
Date: Oct. 31, 2023 · CIK: 0001661053 · Accession: 0000000000-23-011929
AI Filing Summary & Sentiment
File numbers found in text: 333-275187
Letter
United States securities and exchange commission logo October 31, 2023 Robert A. Berman Chief Executive Officer enVVeno Medical Corporation 70 Doppler Irvine, California 92618 Re:enVVeno Medical Corporation Registration Statement on Form S-3 Filed October 26, 2023 File No. 333-275187 Dear Robert A. Berman: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Conlon Danberg at 202-551-4466 with any questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Matthew Bernstein, Esq.
Show Raw Text
United States securities and exchange commission logo
October 31, 2023
Robert A. Berman
Chief Executive Officer
enVVeno Medical Corporation
70 Doppler
Irvine, California 92618
Re:enVVeno Medical Corporation
Registration Statement on Form S-3
Filed October 26, 2023
File No. 333-275187
Dear Robert A. Berman:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Conlon Danberg at 202-551-4466 with any questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc: Matthew Bernstein, Esq.